Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya
AIDS Research and Human Retroviruses · 2024
DOI: 10.1089/aid.2023.0068 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, 2024. Verfasst von Bhavna H Chohan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: HIV Infections, Drug Resistance, Viral, Substance Abuse, Intravenous, Sexual Partners. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
We evaluated the prevalence and correlates of HIV viral nonsuppression and HIV drug resistance (HIV-DR) in a cohort of people who inject drugs living with HIV (PWID-LH) and their sexual and injecting partners living with HIV in Kenya. HIV-DR testing was performed on participants with viral nonsuppression. Of 859 PWID-LH and their partners, 623 (72.5%) were on antiretroviral therapy (ART) ≥4 months and 148/623 (23.8%) were not virally suppressed. Viral nonsuppression was more common among younger participants and those on ART for a shorter duration. Among 122/148 (82.4%) successfully sequenced samples, 55 (45.1%) had detectable major HIV-DR mutations, mainly to non-nucleoside and nucleotide reverse transcriptase inhibitors (NNRTI and NRTI). High levels of HIV-DR among those with viral nonsuppression suggests need for viral load monitoring, adherence counseling, and timely switching to alternate ART regimens in this key population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global Health, University of Washington, Seattle, Washington, USA.
- Kenya Medical Research Institute, Nairobi, Kenya.
- Institute of Public Health Genetics, University of Washington, Seattle, Washington, USA.
- Department of Epidemiology, University of Washington, Seattle, Washington, USA.
- University of Washington Global Assistance Program-Kenya, Nairobi, Kenya.
- KwaZulu-Natal Research Innovation and Sequencing Platform, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Bhavna H Chohan, Ashley S Tseng
Förderung
- NIMH NIH HHS
- NIDA NIH HHS
Zitieren
APA
Chohan, B. H., Kingston, H., Tseng, A. S., Sambai, B., Guthrie, B. L., Wilkinson, E., Giandhari, J., Mbogo, L. W., Monroe-Wise, A., Masyuko, S., Bosire, R., Ludwig-Barron, N. T., Sinkele, W., Bukusi, D., de Oliveria, T., Farquhar, C., & Herbeck, J. T. (2024). Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2023.0068
Vancouver
Chohan BH, Kingston H, Tseng AS, Sambai B, Guthrie BL, Wilkinson E, et al. Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya. AIDS Research and Human Retroviruses. 2024. doi:10.1089/aid.2023.0068
BibTeX
@article{Chohan2024,
author = {Chohan, Bhavna H and Kingston, Hanley and Tseng, Ashley S and Sambai, Betsy and Guthrie, Brandon L and Wilkinson, Eduan and Giandhari, Jennifer and Mbogo, Loice W and Monroe-Wise, Aliza and Masyuko, Sarah and Bosire, Rose and Ludwig-Barron, Natasha T and Sinkele, William and Bukusi, David and de Oliveria, Tulio and Farquhar, Carey and Herbeck, Joshua T},
title = {Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya},
journal = {AIDS Research and Human Retroviruses},
year = {2024},
doi = {10.1089/aid.2023.0068}
}
EUVIMED